Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

During the Trading Day
46.02 +0.38 / +0.83%
As of 4:04pm ET
Day’s Change
During After-Hours   Switch to standard view »
46.99 +0.97 / +2.11%
Volume: 137.4K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 3
Quarter 4
Quarter 1
Quarter 2
Operating ActivitiesNet Income / Starting Line539.0M904.0M2.3B784.0M
Total Other Cash Flow40.0M125.0M-2.7B-149.0M
Funds From Operations934.0M1.4B-10.0M987.0M
Funds From/For Other Operating Expenses-267.0M186.0M-12.0M46.0M
Net Cash Flow - Operating Activities1.2B1.2B2.0M941.0M
InvestingIncrease In Investments---1.5B-213.0M-1.8B
Decrease In Investments2.2B2.3B----
Capital Expenditures-277.0M-287.0M-235.0M-216.0M
Fixed Asset Disposal----230.0M2.3B
Net Assets From Acquisitions -2.8B-495.0M----
Other Investing - Sources35.0M13.0M13.0M15.0M
Net Cash Flow Investing-825.0M-10.0M-205.0M242.0M
FinancingShort Term Borrowings397.0M74.0M-1.5B-47.0M
Long Term Borrowings0.000.002.5B0.00
Long Term Debt Reduction0.00-577.0M-10.0M-23.0M
Net Proceeds Stock Sale64.0M139.0M156.0M57.0M
Common Preferred Redeemed-1.0M-1.0M-1.3B-1.0M
Common Dividends----------
Cash Dividends Paid - Total-331.0M-335.0M-364.0M-360.0M
Other Sources - Financing0.
Other Uses - Financing400.0M0.000.000.00
Net Cash Flow - Financing-271.0M-700.0M-550.0M-374.0M
Exchange RateEffect of Exchange Rate on Cash-62.0M-78.0M-84.0M13.0M
Net Change In Cash105.0M528.0M-753.0M809.0M